Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and Men
- 1 June 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (6), 1050-1059
- https://doi.org/10.1161/atvbaha.107.158998
Abstract
Peroxisome proliferator-activated receptors (PPARs) and (liver X receptors) LXRs are ligand-activated transcription factors that control lipid and glucose metabolism, as well as the inflammatory response. Because the macrophage plays an important role in host defense and immunoinflammatory pathologies, particular attention has been paid to the role of PPARs and LXRs in the control of macrophage gene expression and function. Research over the last few years has revealed important roles for PPAR-α, PPAR-γ, and LXRs in macrophage inflammation and cholesterol homeostasis with consequences for atherosclerosis development. In this review we will discuss the role of these transcription factors in the control of macrophage activities, with particular attention to species-differences in macrophage function control by PPARs and LXR between rodents and humans.Keywords
This publication has 99 references indexed in Scilit:
- Translational Therapeutics of DipyridamoleArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoEJCI Insight, 2007
- Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinedionesJCI Insight, 2007
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistanceNature, 2007
- Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPARγMolecular Cell, 2007
- The human myeloperoxidase gene is regulated by LXR and PPARα ligandsBiochemical and Biophysical Research Communications, 2006
- Inflammation and insulin resistanceJCI Insight, 2006
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003